Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 3 years ago Source:  Radcliffe Cardiology
Mumbai, India 25 Nov 2018: One in five young adults in India has high blood pressure, according to research presented at the 70th Annual Conference of the Cardiological Society of India (CSI). That equates to around 80 million people, which is more than the entire UK population. CSI 2018 is being held 22 to 25 November in Mumbai. Joint scientific sessions were held by the European Society of… View more
Added: 3 years ago Source:  Radcliffe Cardiology
First look at the new 2018 European Guidelines for the treatment of high blood pressure 2018 European Society of Cardiology (ESC) and European Society of Hypertension (ESH) Joint Guidelines for the Management of Arterial Hypertension Barcelona June 9, 2018: A first look at the new European Guidelines for the treatment of high blood pressure was presented at the European Society of Hypertension… View more
Added: 3 years ago
November 13, 2017Categories:Scientific Statements/Guidelines Highlights High blood pressure is now defined as readings of 130 mm Hg and higher for the systolic blood pressure measurement, or readings of 80 and higher for the diastolic measurement. That is a change from the old definition of 140/90 and higher, reflecting complications that can occur at those lower numbers. In the first update to… View more
Added: 3 years ago
One-third of Patients Not Receiving Defibrillation in Time Patients are not receiving defibrillation soon enough after initial cardiac arrest, according to a study published in the New England Journal of Medicine. Delay in defibrillation—defined as coming after more than two minutes—is associated with a lower survival rate and lower likelihood of return to spontaneous circulation following… View more
Added: 3 years ago
While awareness campaigns may be getting women to go to the hospital more quickly during a heart-attack, a new look at hospital data shows women have longer hospital stays and are more likely than men to die in the hospital after a heart attack. In the study published online in theJournal of the American College of Cardiology, researchers from Yale School of Medicine analyzed 230,684… View more
Added: 3 years ago
By Mark Watson Results from the British Hypertension Society’s (BHS) study Pathway-1 reveals that treating early stage hypertension with two medicines at the same time rather than one can significantly reduce blood pressure and may cut the subsequent risk of strokes and heart attacks. The study allocated both hydrochlorothiazide and losartanto to 304 patients who had untreated high blood pressure… View more
Added: 3 years ago
New Technique to Aid Early Diagnosis of Pulmonary Hypertension in Scleroderma Patients Researchers have developed an innovative system to help doctors make earlier diagnosis of pulmonary hypertension in patients suffering from scleroderma. This rare disease, affecting around 1,200 people per million, is a systemic autoimmune disorder acting on multiple organs and is most commonly characterised by… View more
Added: 3 years ago
Doctors Proactive in Pre-diagnosis Treatment of Heart Attacks Doctors are treating patients with a suspected heart attack as aggressively as they are patients who have been diagnosed with an attack. Researchers from Wake Forest University School of Medicine analyzed patient data from over 450 hospitals in 12 countries. They compared the treatment received by patients with different levels of… View more
Added: 3 years ago Source:  Radcliffe News Team
New research has found that metformin – a cheap drug routinely used for the treatment of type 2 diabetes – could help millions of people living with heart and circulatory disease in the UK. Two studies involving the drug, led by researchers at the University of Dundee and presented today at the British Cardiovascular Society (BCS) Conference in Manchester, have provided promising results for… View more
Added: 3 years ago Source:  racepointglobal
St. Jude Preliminary Results from the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation is Safe and Effective Results from the EnligHTN I, II and III trials presented during EuroPCR add to the growing body of clinical evidence supporting the benefits of EnligHTN renal denervation technologies ST. PAUL, Minn. and PARIS – May 22, 2014 – St. Jude Medical, Inc. (NYSE:STJ), a… View more